On September 28, 2022, the Food and Drug Administration (FDA) issued Clinical Decision Support Software final guidance. The guidance clarifies the agency’s scope of oversight and regulation of clinical decision support software based on the definition of a device in the Federal Food, Drug, and Cosmetic Act (FD&C Act). It also describes the criteria used to assess whether software functions do not meet the definition of a device.
John Fuson
As seen in:
Bloomberg Law,
Law360,
Bloomberg Industry Group,
Clarksville Now,
LexBlog,
C&M Health Law
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by John Fuson
The FDA Releases New Draft Guidance on Considering Health Care Disparities When Reviewing Proposed Devices
On October 21st, the U.S. Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency’s 2018 guidance on its Breakthrough Devices Program (the “Program”). In the draft guidance, the FDA announced that when reviewing the eligibility of medical devices for the Program, the agency will also consider whether a device will help address health care disparities and promote health equity.
The FDA Releases New Draft Guidance on Considering Health Care Disparities When Reviewing Proposed Devices
On October 21st, the U.S. Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency’s 2018 guidance on its Breakthrough Devices Program (the “Program”). In the draft guidance, the FDA announced that when reviewing the eligibility of medical devices for the Program, the agency will also consider whether a device will help address health care disparities and promote health equity.
FDA Issues Final Guidance on Clinical Decision Support Software
On September 28, 2022, the Food and Drug Administration (FDA) issued Clinical Decision Support Software final guidance. The guidance clarifies the agency’s scope of oversight and regulation of clinical decision support software based on the definition of a device in the Federal Food, Drug, and Cosmetic Act (FD&C Act). It also describes the criteria used to assess whether software functions do not meet the definition of a device.
Sheriff John Fuson endorses Wes Golden for Montgomery County mayor | OPINION
Clarksville Now publishes opinion pieces representing both sides of a variety of topics. Opinions presented do not necessarily reflect those of the newsroom or management. To join the conversation, email your opinion piece to news@clarksvillenow.com. Contributed commentary by Montgomery County Sheriff John Fuson: I am honored to announce my endorsement and full support of Wes Golden to be our next Montgomery County mayor. I have had the opportunity to work with Wes during the last couple of years.
Letter: Sheriff endorses Wendy Davis for Circuit Court Clerk
Contributed commentary from Sheriff John Fuson: It is my honor to endorse and support Wendy J. Davis to be Montgomery County’s next Circuit Court Clerk. I have known Wendy since the beginning of my career with the Montgomery County Sheriff’s Office. Her leadership, knowledge, willingness to go the extra mile for her team, and all of those who interact with the Circuit Court Clerk’s office, have always impressed me.
Key Regulatory Concerns For Cos. Making COVID-19 Products
By Cheryl Falvey, John Fuson and Mariam Sarwar Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our daily newsletters. Signing up for any of our section newsletters will opt you in to the daily Coronavirus briefing.
FinCEN Provides Additional Guidance for Financial Institutions on Hemp-Related Businesses
On June 29, 2020, the Financial Crimes Enforcement Network (FinCEN) issued helpful guidance on due diligence requirements for hemp-related businesses under the Bank Secrecy Act (BSA).
The Regulatory Pathway To A Vaccine For COVID-19
By John Fuson, Anne Li and Mena Gaballah Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our daily newsletters. Signing up for any of our section newsletters will opt you in to the daily Coronavirus briefing.
INSIGHT: Litigation Risks Related to the Defense Production Act
To help hospitals and other health care providers address shortages of critical medical products, the Food and Drug Administration has issued a dizzying array of emergency use authorizations and relaxed its enforcement policies. Shortages are likely to continue for some time, however, and we anticipate pressure will build to expand use of the Defense Production Act of 1950.
INSIGHT: Litigation Risks Related to the Defense Production Act
To help hospitals and other health care providers address shortages of critical medical products, the Food and Drug Administration has issued a dizzying array of emergency use authorizations and relaxed its enforcement policies. Shortages are likely to continue for some time, however, and we anticipate pressure will build to expand use of the Defense Production Act of 1950.
COVID-19 Countermeasure Protections Are Not Absolute
By Rebecca Chaney, Cheryl Falvey, John Fuson, Scott Winkelman, Clifford Zatz and Mariam Sarwar By Rebecca Chaney, Cheryl Falvey, John Fuson, Scott Winkelman, Clifford Zatz and Mariam Sarwar April 8, 2020, 5:55 PM EDT Law360 (April 8, 2020, 5:55 PM EDT) -- Rebecca Chaney Cheryl Falvey John Fuson Scott Winkelman Clifford Zatz Mariam Sarwar As cases of COVID-19 continue to rise around the country, federal, state and local governments have been racing to ensure that the country is adequately...
In Response to COVID-19 Pandemic, FDA Temporarily Changes Nutrition Label Rules for Restaurants and Food Manufacturers
Mar.27.2020 As a result of the COVID-19 Pandemic, restaurants may have food on hand that they can no longer use to prepare food for patrons. Similarly, food manufacturers may have inventory labeled for use in restaurants that is no longer in demand by the restaurant industry.
PREP Act Immunity from Liability for COVID-19 Related Medical Equipment
Mar.27.2020 Everyone wants to help by providing necessary equipment to the COVID-19 frontline: hospitals, doctors, nurses, and other healthcare providers battling COVID-19 need ventilators, masks, gowns and other supplies. Here are answers to commonly asked questions on how companies position themselves to obtain the immunity from liability provided by The Public Readiness and Emergency Preparedness Act (“PREP Act”). Read more about the PREP Act in our earlier alert. 1.
FDA Cracks Down on Health Claims in CBD Advertisements
When the U.S. Food & Drug Administration (FDA) issued 15 warning letters to companies selling CBD-infused products late last year, it more than doubled the number of warning letters directed to manufacturers of such products in 2019.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with John
Contact John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack